細(xì)胞名稱

AE-1雜交瘤細(xì)胞抗AChE

描述

動(dòng)物用純化的人紅細(xì)胞乙酰*脂酶免疫。 脾細(xì)胞與gp2/O-Agl4骨髓瘤細(xì)胞融合。 產(chǎn)生的抗體與人及猴的乙酰*脂酶結(jié)合，但反應(yīng)位點(diǎn)與AE-2(ATCC HB-73)的抗原決定簇不同。 檢測發(fā)現(xiàn)短肢畸形(鼠痘)病毒陰性。

動(dòng)物種別

小鼠B細(xì)胞x小鼠淋巴瘤

性別

***

組織來源

B淋巴細(xì)胞,淋巴瘤

形態(tài)

淋巴母細(xì)胞

培養(yǎng)基和添加劑

DMEM培養(yǎng)基(GIBCO,貨號12800017，添加NaHCO3 1.5g/L)，90%；優(yōu)質(zhì)胎牛血清，10%。 氣相：空氣，95%；二氧化碳，5%。 溫度：37攝氏度。

供應(yīng)限制

REFERENCE

Fambrough DM, Engel AG, Rosenberry TL. Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies. Proc Natl. Acad. Sci. USA 79:1078-1082, 1982. PubMed: 6175961 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2~d edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J Tissue Culture Methods 11:223-227, 1988. Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC. Centers for Disease Control (1993), Biosafi~ty in Microbiological and Biomedical Laboratories Human Health Service Publication No. (CDC) 93-8395. U.S. Dept. of Health and Human Services; 3rd Edition U.S. Government Printing Office Washington D.C.